[ET Net News Agency, 15 July 2026] HANSOH PHARMA (03692) rose 5.5% to HK$34.34.
It hits an intra-day high of HK$34.34, breaking above the 100-D SMA of HK$33.77, and an intra-day low of HK$32.56. The total shares traded was 9.58 million, with a value of HK$320.84m. The active buy/sell ratio is 61:39, with net buying turnover of HK$64.42m. HUATAI FIN HLDGS HK accounts for greatest net responsive buying turnover of HK$10.32m, with volume weighted average price of HK$33.535. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling turnover of HK$18m, with volume weighted average price of HK$33.478. The stock has risen a combined 10.2% over the past 4 consecutive trading days.
The Hang Seng Index now rose 330 points, or 1.4% to 24,671; the Hang Seng China Enterprises Index now rose 87 points, or 1.1% to 8,190.
Basic Information| Nominal | 34.340 | % Chg | +5.47% |
| High | 34.340 | Low | 32.560 |
| Shares Tr | 9.58m | Turnover | 320.84m |
| 10-D SMA | 32.620 | %H.V | 47.514 |
| 20-D SMA | 30.970 | VWAP | 33.475 |
| 50-D SMA | 32.124 | RSI14 | 63.715 |
Status: Breaking above the 100-D SMA, active buy/sell ratio is 61:39, with net buying turnover of HK$64.42m, rising a combined 10.2% over the past 4 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 34.34 | +5.47 |
| SIHUAN PHARM (00460) | 0.90 | Unchanged |
| GRAND PHARMA (00512) | 5.35 | +2.88 |
| SBP GROUP (01177) | 5.36 | +4.89 |
| HENGRUI PHARMA (01276) | 59.40 | +1.89 |
| LIVZON PHARMA (01513) | 26.56 | +1.61 |
| LUYE PHARMA (02186) | 2.30 | +5.99 |
| FOSUN PHARMA (02196) | 17.09 | +3.26 |
| SH PHARMA (02607) | 11.84 | +3.18 |
| CHINARES PHARMA (03320) | 4.63 | +0.22 |
(ed)
